FORTIS HEALTHCARE Latest Share Price (FORTIS)
TODAY IN ONE LINE
FORTIS fell 1.6% on light volume, lagging Nifty's -0.3% move, supported by recent strong earnings.
With a market cap of ₹66,987.44 Cr., it trades at a P/E of 63.93. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
FORTIS HEALTHCARE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 44.3% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 420.0% and Profit up 470.9%
- ●Healthy Operating MarginsOPM is structurally strong at 18.2%
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.28x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 68.8x
- ●Promoter SellingPromoter holding decreased by 31.17% QoQ
- ●Rising Receivables vs SalesReceivables grew 20.9% outpacing sales growth of 12.9%
Latest FORTIS HEALTHCARE News
What changed recently?
Recent events, corporate actions, and announcements.
FORTIS HEALTHCARE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for FORTIS HEALTHCARE, framed against the sector median so the premium or discount is obvious at a glance.
FORTIS HEALTHCARE trades at a P/E of 63.93× and P/B of 6.77×, against the Healthcare sector median P/E of 46.02×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
FORTIS HEALTHCARE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for FORTIS HEALTHCARE — derived from the latest tape, not yesterday's close.
FORTIS HEALTHCARE last traded at ₹887.8 with an intraday range of ₹885–₹900 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹887.80| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 926.87 | +39.07 | +4.40% |
| R3 | 911.87 | +24.07 | +2.71% |
| R2 | 905.93 | +18.13 | +2.04% |
| R1 | 896.87 | +9.07 | +1.02% |
| PIVOT | 890.93 | 3.13 | 0.35% |
| CURRENT | 887.80 | — | — |
| S1 | 881.87 | -5.93 | -0.67% |
| S2 | 875.93 | -11.87 | -1.34% |
| S3 | 866.87 | -20.93 | -2.36% |
| S4 | 851.87 | -35.93 | -4.05% |
FORTIS is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹885–₹897.95
Trading Below opening range, showing Bearishness
FORTIS HEALTHCARE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for FORTIS HEALTHCARE — consolidated or standalone — with margins, YoY growth and key ratios inline.
FORTIS HEALTHCARE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹66,987.44 Cr. and reported EPS of ₹3.53.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 7,783 | 9,128 ▲ 17.3% |
| Sales Growth YoY %Derived | 12.91% | 17.28% |
| Other Income | 67 | 51 ▼ 24.3% |
| Total Income | 7,850 | 9,179 ▲ 16.9% |
| 1,830 | 2,089 ▲ 14.1% | |
| Gross ProfitDerived | 5,953 | 7,039 ▲ 18.3% |
| Gross Margin %Derived | 76.48% | 77.12% |
| 4,365 | 4,954 ▲ 13.5% | |
| EBITDA (Operating Profit)Derived | 1,588 | 2,085 ▲ 31.3% |
| OPM %Derived | 20.40% | 22.84% |
| 481 | 742 ▲ 54.3% | |
| Profit Before Tax (PBT) | 996 | 1,350 ▲ 35.6% |
| 198 | 302 ▲ 52.6% | |
| Effective Tax %Derived | 19.85% | 22.35% |
| Total Profit for Period | 809 | 1,064 ▲ 31.5% |
| Less: Non-controlling Interests | 35 | 22 ▼ 36.3% |
| Net Profit (Owner's PAT)Derived | 774 | 1,042 ▲ 34.6% |
| Net Profit Margin %Derived | 9.95% | 11.41% |
| PAT Growth YoY %Derived | 29.28% | 34.56% |
| Earnings Per Share (EPS ₹) | 10.26 | 13.80 ▲ 34.5% |
| Diluted Shares Outstanding (Cr) | 75 | 75 ▲ 0.0% |
| Share of Profit from Associates/JVs | 12 | 16 ▲ 41.9% |
| Other Comprehensive Income (Net of Tax) | -4 | 13 ▲ 458.8% |
| Total Expenses (incl. D&A & Interest) | 6,854 | 7,829 ▲ 14.2% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 15.00% | 14.21% |
| Other Cost % of RevenueDerived | 41.08% | 40.07% |
| Interest Coverage (x)Derived | 6.52x | 5.20x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 4,561 | 4,469 ▼ 2.0% | 4,632 ▲ 3.6% | 4,030 ▼ 13.0% | 5,718 ▲ 41.9% | 6,298 ▲ 10.1% | 6,893 ▲ 9.5% | 7,783 ▲ 12.9% | 9,128 ▲ 17.3% | |
| Sales Growth YoY %Derived | — | -2.01% | 3.65% | -13.00% | 41.87% | 10.14% | 9.45% | 12.91% | 17.28% | |
| Other Income | 140 | 92 ▼ 33.9% | 53 ▼ 43.0% | 47 ▼ 11.6% | 27 ▼ 41.3% | 62 ▲ 125.7% | 38 ▼ 38.0% | 67 ▲ 75.0% | 51 ▼ 24.3% | |
| Total Income | 4,701 | 4,562 ▼ 3.0% | 4,685 ▲ 2.7% | 4,077 ▼ 13.0% | 5,745 ▲ 40.9% | 6,359 ▲ 10.7% | 6,931 ▲ 9.0% | 7,850 ▲ 13.3% | 9,179 ▲ 16.9% | |
999 | 928 ▼ 7.1% | 964 ▲ 3.8% | 976 ▲ 1.3% | 1,357 ▲ 39.1% | 1,455 ▲ 7.2% | 1,619 ▲ 11.3% | 1,830 ▲ 13.1% | 2,089 ▲ 14.1% | ||
| Gross ProfitDerived | 3,562 | 3,541 ▼ 0.6% | 3,668 ▲ 3.6% | 3,054 ▼ 16.7% | 4,360 ▲ 42.8% | 4,843 ▲ 11.1% | 5,274 ▲ 8.9% | 5,953 ▲ 12.9% | 7,039 ▲ 18.3% | |
| Gross Margin %Derived | 78.10% | 79.23% | 79.19% | 75.78% | 76.26% | 76.90% | 76.52% | 76.48% | 77.12% | |
3,289 | 3,316 ▲ 0.8% | 3,059 ▼ 7.7% | 2,650 ▼ 13.4% | 3,291 ▲ 24.2% | 3,742 ▲ 13.7% | 4,007 ▲ 7.1% | 4,365 ▲ 8.9% | 4,954 ▲ 13.5% | ||
| EBITDA (Operating Profit)Derived | 273 | 225 ▼ 17.5% | 610 ▲ 170.6% | 404 ▼ 33.6% | 1,069 ▲ 164.3% | 1,101 ▲ 3.0% | 1,268 ▲ 15.1% | 1,588 ▲ 25.3% | 2,085 ▲ 31.3% | |
| OPM %Derived | 5.99% | 5.04% | 13.16% | 10.04% | 18.70% | 17.49% | 18.39% | 20.40% | 22.84% | |
-384 | 347 ▲ 190.4% | 559 ▲ 60.8% | 458 ▼ 18.1% | 763 ▲ 66.6% | 518 ▼ 32.0% | 489 ▼ 5.6% | 481 ▼ 1.8% | 742 ▲ 54.3% | ||
| Profit Before Tax (PBT) | -965 | -475 ▲ 50.8% | 227 ▲ 147.9% | -4 ▼ 101.9% | 964 ▲ 22667.7% | 792 ▼ 17.8% | 848 ▲ 7.2% | 996 ▲ 17.3% | 1,350 ▲ 35.6% | |
23 | 114 ▲ 401.6% | 148 ▲ 30.2% | 99 ▼ 32.7% | 198 ▲ 98.9% | 181 ▼ 8.7% | 213 ▲ 17.7% | 198 ▼ 7.1% | 302 ▲ 52.6% | ||
| Effective Tax %Derived | -2.35% | -23.94% | 65.08% | -2,329.27% | 20.53% | 22.82% | 25.07% | 19.85% | 22.35% | |
| Total Profit for Period | -934 | -224 ▲ 76.1% | 91 ▲ 140.9% | -56 ▼ 161.4% | 790 ▲ 1506.4% | 633 ▼ 19.9% | 645 ▲ 1.9% | 809 ▲ 25.4% | 1,064 ▲ 31.5% | |
| Less: Non-controlling Interests | 75 | — ▼ 100.0% | 34 | 54 ▲ 59.7% | 235 ▲ 338.2% | 44 ▼ 81.2% | 46 ▲ 4.7% | 35 ▼ 24.1% | 22 ▼ 36.3% | |
| Net Profit (Owner's PAT)Derived | -1,009 | -224 ▲ 77.8% | 58 ▲ 125.9% | -110 ▼ 289.4% | 555 ▲ 605.8% | 589 ▲ 6.1% | 599 ▲ 1.7% | 774 ▲ 29.3% | 1,042 ▲ 34.6% | |
| Net Profit Margin %Derived | -22.13% | -5.01% | 1.25% | -2.72% | 9.71% | 9.35% | 8.69% | 9.95% | 11.41% | |
| PAT Growth YoY %Derived | — | 77.83% | 125.90% | -289.45% | 605.76% | 6.05% | 1.72% | 29.28% | 34.56% | |
| Earnings Per Share (EPS ₹) | -19.46 | -2.96 ▲ 84.8% | 0.77 ▲ 126.0% | -1.45 ▼ 288.3% | 7.35 ▲ 606.9% | 7.80 ▲ 6.1% | 7.93 ▲ 1.7% | 10.26 ▲ 29.4% | 13.80 ▲ 34.5% | |
| Diluted Shares Outstanding (Cr) | 52 | 75 ▲ 45.6% | 75 ▲ 0.0% | 75 ▲ 0.0% | 75 ▲ 0.0% | 75 ▲ 0.0% | 75 ▲ 0.0% | 75 ▲ 0.0% | 75 ▲ 0.0% | |
| Share of Profit from Associates/JVs | 53 | 364 ▲ 585.5% | 12 ▼ 96.7% | 48 ▲ 291.1% | 24 ▼ 49.2% | 22 ▼ 9.6% | 10 ▼ 56.5% | 12 ▲ 21.1% | 16 ▲ 41.9% | |
| Other Comprehensive Income (Net of Tax) | 4 | -45 ▼ 1330.8% | 0 ▲ 100.2% | 10 ▲ 9300.0% | -47 ▼ 549.7% | -8 ▲ 83.1% | 2 ▲ 122.6% | -4 ▼ 297.8% | 13 ▲ 458.8% | |
| Total Expenses (incl. D&A & Interest) | 5,665 | 5,036 ▼ 11.1% | 4,458 ▼ 11.5% | 4,081 ▼ 8.5% | 4,781 ▲ 17.2% | 5,568 ▲ 16.4% | 6,083 ▲ 9.3% | 6,854 ▲ 12.7% | 7,829 ▲ 14.2% | |
| Material Cost % of RevenueDerived | 21.90% | 20.77% | 20.81% | 24.22% | — | — | — | — | — | |
| Employee Cost % of RevenueDerived | 19.86% | 20.44% | 19.77% | 21.07% | 17.02% | 16.62% | 16.24% | 15.00% | 14.21% | |
| Other Cost % of RevenueDerived | 52.25% | 53.75% | 46.26% | 44.68% | 40.55% | 42.79% | 41.88% | 41.08% | 40.07% | |
| Interest Coverage (x)Derived | 0.13x | -0.02x | 1.55x | 0.69x | 5.23x | 6.09x | 7.06x | 6.52x | 5.20x |
FORTIS HEALTHCARE segment analysis : revenue and profit mix.
Disclosed business segments at FORTIS HEALTHCARE with their share of revenue and profit, switchable between consolidated and standalone reporting.
FORTIS HEALTHCARE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for FORTIS HEALTHCARE.
Our AI distills the core fundamental drivers supporting FORTIS HEALTHCARE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
FORTIS HEALTHCARE's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Latest quarterly EPS grew 44.6% YoY, demonstrating strong earnings acceleration momentum.
Operating margin 17.92% significantly exceeds Apollo 11.13%, signaling superior pricing power.
TTM revenue growth 17.8% YoY positions company ahead of peer expansion rates competitively.
Low debt-to-equity 0.0021x maintains healthy leverage for growth investments and flexibility.
Net margin 11.41% outpaces Apollo 7.56%, demonstrating operational efficiency edge in tertiary care.
Key Risks.
P/E 68.81x far exceeds peer median, exposing significant valuation risk and downside.
Dividend yield 0.11% minimal, offering limited income to shareholders seeking returns.
Operating cash flow declined sharply to ₹116.12 Cr (FY2026) from ₹334.02 Cr (FY2025).
ROE 2.50% and ROCE 2.84% significantly trail peer averages, indicating weak capital deployment.
Working capital deterioration ₹3,970.8 Cr (9M FY2025) pressures operational efficiency metrics.
Flip Conditions.
Valuation risk. a P/E above 83 (~1.8× the sector multiple of 46.0) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
FORTIS HEALTHCARE peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — FORTIS HEALTHCARE is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
FORTIS HEALTHCARE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for FORTIS HEALTHCARE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
FORTIS HEALTHCARE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for FORTIS HEALTHCARE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in FORTIS HEALTHCARE stood at 45.2% of traded volume, against a 20-day average of 53.7%.
FORTIS HEALTHCARE announcements: results, concalls, ratings, M&A.
Filings FORTIS HEALTHCARE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
FORTIS HEALTHCARE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 257 documents below.
General Updates
Fortis Healthcare Limited has informed the Exchange about General Updates
Analysts/Institutional Investor Meet/Con. Call Updates
Fortis Healthcare Limited has informed the Exchange about Transcript of Investors / Analysts meet held on Friday, September 4, 2026, on the recent…
Analysts/Institutional Investor Meet/Con. Call Updates
Fortis Healthcare Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates
Fortis Healthcare Limited has informed the Exchange about Schedule of meets.
Analysts/Institutional Investor Meet/Con. Call Updates
Fortis Healthcare Limited has informed the Exchange about Link of Recording
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
FORTIS HEALTHCARE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue FORTIS HEALTHCARE has declared, sequenced by announce and record date.
FORTIS HEALTHCARE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About FORTIS HEALTHCARE: business, sector, key facts.
What FORTIS HEALTHCARE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
FORTIS HEALTHCARE operates in the Hospital industry under the Healthcare sector, listed as NSE: FORTIS, BSE: 532843.
Fortis Healthcare Limited is a major integrated healthcare provider in India, focusing on delivering a comprehensive range of secondary, tertiary, and quaternary care services. This means they handle a wide spectrum of medical needs, from routine care to highly specialized and complex treatments.
The breadth of their medical offerings is extensive, covering a vast array of specialties. This includes, but is not limited to, cardiology, oncology, neurology, orthopedics, gastroenterology, and various other surgical and medical disciplines. They also provide services in areas like cosmetology, dermatology, and mental health, demonstrating a commitment to a holistic approach to patient care.
Fortis operates across multiple healthcare verticals, ensuring a diversified and integrated healthcare delivery system. Their core business includes a network of hospitals, offering inpatient and outpatient services. In addition to hospitals, they also operate diagnostic centers and specialized day-care facilities, providing convenient access to a range of tests and procedures.
The company’s business model is centered around providing high-quality healthcare services across a wide range of specialties. Their presence in multiple healthcare verticals allows for a cohesive and comprehensive approach to patient care, from initial diagnosis and treatment to specialized procedures and ongoing support. This integrated approach aims to deliver a seamless and efficient healthcare experience.
Established in 1995 and headquartered in Gurugram, India, Fortis Healthcare Limited has a significant presence within the Indian healthcare market. Their wide range of services and multi-vertical approach positions them as a key player in the country's healthcare landscape.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- DR AGARWALS HEALTH CARE L (AGARWALEYE) Share PricePeer
- APOLLO HOSPITALS ENTER L (APOLLOHOSP) Share PricePeer
- ARTEMIS MED SERVICE (ARTEMISMED) Share PricePeer
- ASTER DM QUALITY CARE (ASTERDM) Share PricePeer
- GPT HEALTHCARE (GPTHEALTH) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about FORTIS HEALTHCARE (FORTIS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of FORTIS HEALTHCARE (FORTIS)?
The current share price of FORTIS HEALTHCARE (FORTIS) is ₹887.80. Today, the stock has declined by ₹14.65 (1.62%), trading in a range of ₹885.00 to ₹900.00. The stock opened at ₹897.50 with a trading volume of 7,84,589 shares.
02Is FORTIS HEALTHCARE stock a good investment for long-term?
FORTIS HEALTHCARE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹66,987.44 Cr., P/E ratio of 63.93, ROE of 10.47%, and ROCE of 10.23%. The dividend yield stands at 0.11%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of FORTIS HEALTHCARE stock?
The 52-week high price of FORTIS HEALTHCARE (FORTIS) is ₹1,104.30, while the 52-week low is ₹766.80. Currently trading at ₹887.80, the stock is 15.78% above its 52-week low and 19.61% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy FORTIS HEALTHCARE stock at the current price?
Whether to buy FORTIS HEALTHCARE stock at ₹887.80 depends on multiple factors. The stock is currently trading with a P/E ratio of 63.93 and P/B ratio of 6.77. Today's performance shows a loss of 1.62%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of FORTIS HEALTHCARE and when is the next dividend?
FORTIS HEALTHCARE offers a dividend yield of 0.11%, which means for every ₹100 invested at the current price of ₹887.80, you can expect to receive approximately ₹0.11 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of FORTIS HEALTHCARE?
FORTIS HEALTHCARE's key financial metrics include: P/E Ratio: 63.93, P/B Ratio: 6.77, ROE: 10.47%, ROCE: 10.23%, Dividend Yield: 0.11%, EPS: ₹3.53, Book Value: ₹134.69, and Debt-to-Equity: 0.28. The company's market cap stands at ₹66,987.44 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is FORTIS HEALTHCARE stock performing today in the market?
FORTIS HEALTHCARE stock opened at ₹897.50 and is currently trading at ₹887.80, showing a decline of ₹14.65 (1.62%). The intraday high is ₹900.00 and low is ₹885.00. The trading volume stands at 7,84,589 shares, indicating moderate market participation today.
08What is the P/E ratio of FORTIS HEALTHCARE and what does it indicate?
FORTIS HEALTHCARE has a Price-to-Earnings (P/E) ratio of 63.93, which means investors are willing to pay 63.93 for every ₹1 of earnings. With an EPS of ₹3.53, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about FORTIS HEALTHCARE (FORTIS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.